| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/31/2004 | EP1402031A2 Atopy |
| 03/31/2004 | EP1402019A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 03/31/2004 | EP1402015A2 A soluble complex comprising a retroviral surface glycoprotein |
| 03/31/2004 | EP1402009A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
| 03/31/2004 | EP1402006A1 Compositions and methods for high-level, large-scale production of recombinant proteins |
| 03/31/2004 | EP1402005A1 A method of purification of cells |
| 03/31/2004 | EP1402004A2 Remodeling of somatic nuclei upon addition of pluripotent cell extracts |
| 03/31/2004 | EP1402000A2 Structural and cytoskeleton-associated proteins |
| 03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
| 03/31/2004 | EP1401997A1 Apparatus for and methods of preparing sperm |
| 03/31/2004 | EP1401869A1 Molecules and methods for inhibiting shedding of kim-1 |
| 03/31/2004 | EP1401861A2 Cads as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401855A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 03/31/2004 | EP1401849A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 03/31/2004 | EP1401828A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 03/31/2004 | EP1401495A2 T cell induced tissue repair and regeneration |
| 03/31/2004 | EP1401475A2 Prmts as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 03/31/2004 | EP1401342A1 Apparatus for and methods of preparing sperm |
| 03/31/2004 | EP1401282A1 Stem cell differentiation |
| 03/31/2004 | EP1401281A2 Toll/interleukin-1 receptor adaptor protein (tirap) |
| 03/31/2004 | EP1401269A2 Transgenic animal model of bone mass modulation |
| 03/31/2004 | EP1401268A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 03/31/2004 | EP1401259A2 Delta-4 desaturase genes and uses thereof |
| 03/31/2004 | EP1366059A4 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 03/31/2004 | EP1248519A4 Expansion of stem and progenitor cells by beta-catenin |
| 03/31/2004 | EP1235902A4 Olfactory ensheathing cells isolated from the lamina propria |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP1210102A4 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 03/31/2004 | EP1181318B1 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/31/2004 | EP1058849B1 Environmental biosensor for measuring air contaminants |
| 03/31/2004 | EP1003863B1 Mammalian cytokine receptor-11 |
| 03/31/2004 | EP0977578B1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 03/31/2004 | EP0866860B1 Novel tyrosine kinase receptors and ligands |
| 03/31/2004 | EP0852011B1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | EP0746625B1 Targetable vector particles |
| 03/31/2004 | EP0742833B1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
| 03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
| 03/31/2004 | EP0731806B1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | EP0656939B1 Production of graft tissue from extracellular matrix |
| 03/31/2004 | CN1486368A Methods for the production of multimeric proteins, and related compositions |
| 03/31/2004 | CN1486365A Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 03/31/2004 | CN1486328A Method for surface display of proteins on genetic carriers |
| 03/31/2004 | CN1486327A 载脂蛋白类似物 Apolipoprotein analogues |
| 03/31/2004 | CN1486192A Binding domain-immunoglobulin fusion proteins |
| 03/31/2004 | CN1485425A Cotton chitinase and encoding gene and application thereof |
| 03/31/2004 | CN1485094A Natural porous polymer beads, the preparation and application thereof |
| 03/31/2004 | CN1143892C Recombinant sendal virus |
| 03/31/2004 | CN1143618C Precise efficiency assay methods for active agents including chemotherapeutic agents |
| 03/30/2004 | US6713663 Flowering locus T (FT) and genetically modified plants having delayed flower development |
| 03/30/2004 | US6713662 Production of collagen in the milk of transgenic mammals |
| 03/30/2004 | US6713621 Chimeric compositions having multi-modalities are also provided which can affect a plurality of gene functions by interfering with splicing or translation as well as transcription |
| 03/30/2004 | US6713303 Culturing ginseng; obtain ginseng, induce callus, culture in nutrient broth, propagate in bioreactor |
| 03/30/2004 | US6713282 End selection in directed evolution |
| 03/30/2004 | US6713281 Directed evolution of thermophilic enzymes |
| 03/30/2004 | US6713270 Dna encoding a novel steroid receptor is introduced into cell with reporter gene, potential ligand is incubated with cell, production of reporter protein means ligand binds receptor |
| 03/30/2004 | US6713269 Cell culltures for use in detcetion, evaluation and treatment of bone disorders |
| 03/30/2004 | US6713266 Immunoassay method for measuring a cyclosporine and its metabolites |
| 03/30/2004 | US6713249 Soild supports for use in monitoring osteogenesis |
| 03/30/2004 | US6713248 Methods for detection of gamma-secretase activity and identification of inhibitors thereof |
| 03/30/2004 | US6713247 Human CNS cell lines and methods of use therefor |
| 03/30/2004 | US6713245 Contacting a population of porcine neural cells with a hibernation medium to produce a cell suspension; maintaining the cell suspension at about 4 degrees c. to thereby store a population of neural cells suitable for transplantation |
| 03/30/2004 | US6713084 Promoting healing of a laser skin resurfacing wound, preserved sheet of allogeneic or xenogeneic cultured epithelial cells |
| 03/30/2004 | US6713079 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from l-arganine analog, dextran, heparin, cysteine and cystine |
| 03/30/2004 | US6713065 Methods of using hedgehog proteins to modulate hematopoiesis and vascular growth |
| 03/30/2004 | US6713056 Combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 03/30/2004 | US6713055 Glycosyltransferase vectors for treating cancer |
| 03/30/2004 | US6713054 Cellular immunotherapy treatment of patients afflicted with chronic fatigue syndrome |
| 03/30/2004 | CA2235471C Dna encoding a plasminogen activating protein |
| 03/30/2004 | CA2087347C Heterohybridomas producing human monoclonal antibodies to hiv-1 |
| 03/25/2004 | WO2004025293A2 Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells |
| 03/25/2004 | WO2004025266A2 Method and apparatus for sorting particles |
| 03/25/2004 | WO2004025264A2 Rapidly degraded reporter fusion proteins |
| 03/25/2004 | WO2004024938A2 Β1,4-n-acetylgalactosaminyltransferases, nucleic acids and methods of use thereof |
| 03/25/2004 | WO2004024928A2 Transformed plants with enhanced prenylquinone biosynthesis |
| 03/25/2004 | WO2004024925A2 Collectin-complement activating protein chimeras |
| 03/25/2004 | WO2004024915A1 Gene expression system based on codon translation efficiency |
| 03/25/2004 | WO2004024909A2 Recombinant colstridium neurotoxin fragments |
| 03/25/2004 | WO2004024904A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | WO2004024903A1 Method of separating epithelial cells from a human or animal urine sample |
| 03/25/2004 | WO2004024902A1 A method of treating an autoimmune disease |
| 03/25/2004 | WO2004024901A1 REGULATING β-CATENIN LEVELS |
| 03/25/2004 | WO2004024900A1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 03/25/2004 | WO2004024899A1 Growth factor for cell culture |
| 03/25/2004 | WO2004024875A2 Mammalian megakaryocyte progenitor cell |
| 03/25/2004 | WO2004024772A1 Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/ or identifying neuronal precursor cells |
| 03/25/2004 | WO2004024749A2 Thermostable reverse transcriptases and uses thereof |
| 03/25/2004 | WO2004024746A2 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof |
| 03/25/2004 | WO2004024627A1 Method for the production of highly organized crystals by means of sol-gel methods |
| 03/25/2004 | WO2004024227A2 Systems of sperm cell preservation and processing |
| 03/25/2004 | WO2004024171A1 Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine) |
| 03/25/2004 | WO2004024084A2 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | WO2004024068A2 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004016777A3 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests |
| 03/25/2004 | WO2004008100A3 Methods and media for controlling sialylation of proteins produced by mammalian cells |